Skip to main content
. 2025 Apr 9;11(4):296. doi: 10.3390/jof11040296
ACCAs Anti-chitobioside antibodies
AD Alzheimer’s disease
AILD Autoimmune liver disease
ALCAs anti-laminaribioside antibodies
AMCA anti-mannobioside IgG
AMPs Antimicrobial peptides
APCs Antigen-presenting cells
ASCAs Anti-Saccharomyces cerevisiae antibodies
ASD Autism spectrum disorder
ASF mice Altered Schaedler flora mice
BD Behçet’s disease
BD Bipolar disorder
CD Crohn’s disease
CRC Colorectal cancer
DCs Dendritic cells
DIA Dot immunobinding assay
ELISA Enzyme-linked immune sorbent assay
FMT Fecal microbiota transplant
GC-B Germinal center B
IBD Inflammatory bowel disease
IECs Intestinal epithelial cells
Igs Immunoglobulins
IL Interleukin
IMID Immune-mediated inflammatory disease
MAC Membrane attack complex
MALDI-TOF MS Matrix Assisted Laser Desorption Ionisation—Time of Flight Mass Spectrometry
MHC Major histocompatibility complex
MS Multiple sclerosis
nAbs Natural antibodies
NGS Next-generation sequencing
PAMPs Pathogen-associated molecular patterns
PBC Primary biliary cirrhosis
PD Parkinson’s disease
PMNs Polymorphonuclear leukocytes
PRRs Pattern recognition receptors
PSC Primary sclerosing cholangitis
ROS Reactive oxygen species
SCZ Schizophrenia
SD Seborrheic dermatitis
SHM Somatic hypermutation
SWOT Strengths, weaknesses, opportunities, and threats analysis
Tc cells Cytotoxic T cells
TCRs T cell receptors
Tfh cells Follicular helper T cells
Th cells Helper T cells
Treg cells Regulatory T cells
UC Ulcerative Colitis
WB Western blotting